Literature DB >> 27655020

Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.

Shaoan Chen1, Pengpeng Ma2, Ying Zhao3, Bin Li4, Shaobo Jiang1, Hui Xiong1, Zheng Wang1, Hanbo Wang1, Xunbo Jin5, Chuan Liu6.   

Abstract

Long noncoding RNAs (lncRNAs) have been shown to play a critical role in cancer development and progression. LncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) is a kidney cancer-associated onco-lncRNA involved in the progression of renal cell carcinoma (RCC). However, the pathological role of lncRNA MALAT-1 in RCC proliferation and metastasis remains poorly understood. This study was designed to investigate the biological role and mechanism of MALAT-1 in RCC proliferation and metastasis. The experiments were performed in human tissues, renal carcinoma cell lines, and nude mice. The expression of lncRNA MALAT-1, Livin mRNA, and the Livin protein was determined by quantitative real-time PCR (qRT-PCR) or a Western blot. The interaction between MALAT-1 and Livin was evaluated by RNA pull-down and RNA binding protein immunoprecipitation (RIP). Cell viability and apoptosis in RCC cell lines were detected using CCK-8 and TUNEL assays. LncRNA MALAT-1 and the Livin protein were highly expressed in RCC tissues, as well as in RCC 786-O and Caki-1 cell lines. MALAT-1 interference contributed to an increase in cell apoptosis and a reduction in the cell viability of 786-O and Caki-1 cells. The increase in apoptosis by si-MALAT-1 was reversed by overexpression of Livin. The RIP results showed that MALAT-1 promoted the expression of the Livin protein in 786-O and Caki-1 cells by enhancing the stability of the protein. Furthermore, the volume of si-MALAT-1-786-O cell xenograft was significantly suppressed. These data indicate that lncRNA MALAT-1-mediated promotion of RCC proliferation and metastasis may be due to the upregulation of the expression of Livin.

Entities:  

Keywords:  Cell proliferation and metastasis; Livin; LncRNA MALAT-1; Renal cell carcinoma

Mesh:

Substances:

Year:  2016        PMID: 27655020     DOI: 10.1007/s12576-016-0486-8

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  28 in total

1.  The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells.

Authors:  Irena Crnković-Mertens; Thomas Muley; Michael Meister; Bettina Hartenstein; Julia Semzow; Karin Butz; Felix Hoppe-Seyler
Journal:  Lung Cancer       Date:  2006-09-11       Impact factor: 5.705

2.  Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.

Authors:  Yuk Cheung Chan; Sashwati Roy; Savita Khanna; Chandan K Sen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-12       Impact factor: 8.311

Review 3.  miRNAs in atherosclerotic plaque initiation, progression, and rupture.

Authors:  Ioannis Andreou; Xinghui Sun; Peter H Stone; Elazer R Edelman; Mark W Feinberg
Journal:  Trends Mol Med       Date:  2015-03-11       Impact factor: 11.951

4.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Authors:  Hiroshi Hirata; Yuji Hinoda; Varahram Shahryari; Guoren Deng; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer Res       Date:  2015-01-19       Impact factor: 12.701

Review 5.  Nutraceuticals and atherosclerosis: human trials.

Authors:  Lina Badimon; Gemma Vilahur; Teresa Padro
Journal:  Cardiovasc Ther       Date:  2010-08       Impact factor: 3.023

Review 6.  An emerging understanding of long noncoding RNAs in kidney cancer.

Authors:  Shuigen Zhou; Jiandong Wang; Zhengyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

7.  Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.

Authors:  Hai-min Zhang; Feng-qiang Yang; Shao-Jun Chen; Jianping Che; Jun-hua Zheng
Journal:  Tumour Biol       Date:  2014-12-06

8.  Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.

Authors:  Chuan Jin; Bingchuan Yan; Qin Lu; Yanmin Lin; Lei Ma
Journal:  Tumour Biol       Date:  2015-12-16

Review 9.  Biomechanical factors and macrophages in plaque stability.

Authors:  Anusha Seneviratne; Maarten Hulsmans; Paul Holvoet; Claudia Monaco
Journal:  Cardiovasc Res       Date:  2013-05-17       Impact factor: 10.787

10.  Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.

Authors:  N Wagener; I Crnković-Mertens; C Vetter; S Macher-Göppinger; J Bedke; E F Gröne; H Zentgraf; M Pritsch; K Hoppe-Seyler; S Buse; A Haferkamp; F Autschbach; M Hohenfellner; F Hoppe-Seyler
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

View more
  15 in total

1.  Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.

Authors:  Yang Su; Jingxiao Lu; Xianguo Chen; Chaozhao Liang; Pengcheng Luo; Cong Qin; Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-03       Impact factor: 4.553

2.  VELUCT, a long non-coding RNA with an important cellular function despite low abundance.

Authors:  Judit Danis; Márta Széll
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein.

Authors:  Shaoan Chen; Pengpeng Ma; Bin Li; Dawei Zhu; Xiude Chen; Yuzhu Xiang; Tengteng Wang; Xiangbin Ren; Chuan Liu; Xunbo Jin
Journal:  Mol Cell Biochem       Date:  2017-05-03       Impact factor: 3.396

4.  Construction of a Prognostic Model for KIRC and Identification of Drugs Sensitive to Therapies - A Comprehensive Biological Analysis Based on m6A-Related LncRNAs.

Authors:  Dian Xia; Qi Liu; Songbai Yan; Liangkuan Bi
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

5.  Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.

Authors:  Zhujuan Wang; Xiong Chang; Guannan Zhu; Xiaoting Gao; Luyuan Chang
Journal:  Cell Cycle       Date:  2020-07-14       Impact factor: 4.534

Review 6.  Platelet RNA signatures for the detection of cancer.

Authors:  Nik Sol; Thomas Wurdinger
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

7.  Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma.

Authors:  Wenjun Ni; Erlin Song; Mancheng Gong; Yongxiang Li; Jie Yao; Ruihua An
Journal:  Onco Targets Ther       Date:  2017-06-19       Impact factor: 4.147

8.  Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation.

Authors:  Jun Guo; Weiwei Fang; Libo Sun; Yonggang Lu; Lin Dou; Xiuqing Huang; Weiqing Tang; Liqing Yu; Jian Li
Journal:  Nat Commun       Date:  2018-02-09       Impact factor: 14.919

9.  Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Renal Cell Carcinoma Progression via Sponging miRNA-429.

Authors:  Lin-Tao Jiang; Chun-Hua Wan; Qing-Hao Guo; Shi-Jiang Yang; Jing-Dong Wu; Jun Cai
Journal:  Med Sci Monit       Date:  2018-03-28

10.  Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1.

Authors:  Chengluo Jin; Linmei Shi; Kunlun Li; Wei Liu; Yu Qiu; Yakun Zhao; Bai Zhao; Zhexun Li; Yifei Li; Qingguo Zhu
Journal:  Oncol Rep       Date:  2021-07-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.